CANY
NBP

Caxton Associates (New York)’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Caxton Associates (New York)’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25,132
Closed -$75.1K – 507
2023
Q2 		$75.1K Sell
25,132
-28,661
-53% -$92.1K 0.01% 464
2023
Q1 		$186K Buy
53,793
+36,993
+220% +$179K 0.03% 427
2022
Q4 		$70.2K Buy
+16,800
New +$63.6K ﹤0.01% 429

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Caxton Associates (New York)'s NBP Position: Q3 2023 in Review

Caxton Associates (New York) sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2023, closing a stake of 25,132 shares — an estimated $75.1K sold.

Caxton Associates (New York) first reported a position in NBP in Q4 2022 and held it in 3 quarters. The position peaked at $186K in Q1 2023. 47 funds tracked by Wall St. Rank hold NBP as of Q3 2023.

  • Caxton Associates (New York) reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 25,132 NovaBridge Biosciences American Depositary Shares shares in Q3 2023, an estimated $75.1K.
  • Caxton Associates (New York) first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2022 and held it in 3 quarters.
  • Caxton Associates (New York)'s NovaBridge Biosciences American Depositary Shares position peaked at $186K in Q1 2023.
  • 47 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2023.

Based on Caxton Associates (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.